Skip to Main Content

The Food and Drug Administration is considering whether it needs to revamp guidance on how FDA-regulated manufacturers should deal with online misinformation about their products as the agency continues to contend with a deadly tide of falsehoods spreading on social media, Commissioner Robert Califf told STAT.

In an interview, FDA Commissioner Robert Califf said the agency is grappling with how best to handle an explosion of misinformation, including vaccine skepticism that has worsened the toll of Covid-19 pandemic. While the agency is considering whether it can take on misinformation more head-on, he said the FDA might well be able to find a clear path to better support drug, vaccine, and device makers whose products are the targets of misinformation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment